Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19723493 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
Conditions: Type 2 Diabetes Mellitus;   Chronic Liver Disease
Interventions: Drug: UDCA;   Drug: Sitagliptin

Study has passed its completion date and status has not been verified in more than two years.